Published in PLoS One on July 02, 2012
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med (2014) 1.56
Validation of a blood protein signature for non-small cell lung cancer. Clin Proteomics (2014) 0.95
Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol (2015) 0.90
Current readings: blood-based biomarkers for lung cancer. Semin Thorac Cardiovasc Surg (2013) 0.81
A comparison of computer-aided detection (CAD) effectiveness in pulmonary nodule identification using different methods of bone suppression in chest radiographs. J Digit Imaging (2013) 0.80
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark (2012) 0.78
Chemoprevention of lung cancer: prospects and disappointments in human clinical trials. Cancers (Basel) (2013) 0.78
Low-dose CT scan screening for lung cancer: comparison of images and radiation doses between low-dose CT and follow-up standard diagnostic CT. Springerplus (2013) 0.77
Lung cancer: CT screening for lung cancer--do we have an answer? Nat Rev Clin Oncol (2013) 0.75
Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer. Oncoimmunology (2017) 0.75
[Early recognition of lung cancer in workers occupationally exposed to asbestos]. Radiologe (2016) 0.75
Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61
Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med (2006) 19.06
Revisions in the International System for Staging Lung Cancer. Chest (1997) 15.68
Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis (1991) 13.67
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83
Computed tomography screening and lung cancer outcomes. JAMA (2007) 8.01
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer (2008) 6.96
Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 6.79
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10
Lung cancer screening with CT: Mayo Clinic experience. Radiology (2003) 4.72
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med (2009) 4.51
Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst (2006) 4.39
CT screening for lung cancer: five-year prospective experience. Radiology (2005) 4.33
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med (2008) 3.94
Screening for lung cancer. N Engl J Med (2000) 3.85
Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med (2010) 3.79
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology (2007) 3.44
Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology (1996) 3.22
Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest (2010) 3.13
Concern Early lung cancer action project: initial findings on repeat screenings. Cancer (2001) 2.99
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet (2003) 2.95
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax (2012) 2.81
Screening for lung cancer. A critique of the Mayo Lung Project. Cancer (1991) 2.47
Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer (2001) 2.46
Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest (2007) 2.43
Clinical practice. Lung cancer screening. N Engl J Med (2005) 2.19
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis (1984) 2.13
Current cigarette smoking prevalence among working adults--United States, 2004-2010. MMWR Morb Mortal Wkly Rep (2011) 2.09
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05
Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol (2004) 2.01
Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial. Cancer Prev Res (Phila) (2011) 1.98
Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax (2005) 1.92
Doubling times and CT screen–detected lung cancers in the Pittsburgh Lung Screening Study. Am J Respir Crit Care Med (2012) 1.90
CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology (2004) 1.71
Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer (2007) 1.68
Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med (2008) 1.30
Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med (2005) 1.22
Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. J Thorac Oncol (2008) 1.19
Pulmonary nodules 10 mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy. Jpn J Thorac Cardiovasc Surg (2005) 1.18
Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer (2012) 1.12
Staging classification of lung cancer. A critical evaluation. Clin Chest Med (2002) 1.07
Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer (2006) 1.02
Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med (2011) 1.00
An actuarial approach to comparing early stage and late stage lung cancer mortality and survival. Popul Health Manag (2010) 0.94
Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules. Chest (2007) 0.86
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A (2007) 11.85
Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer. J Clin Oncol (2004) 5.08
Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med (2002) 4.99
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol (2009) 3.47
CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol (2002) 3.41
Detection of lung cancer with volatile markers in the breath. Chest (2003) 3.09
SERRATE is a novel nuclear regulator in primary microRNA processing in Arabidopsis. Plant J (2006) 2.98
A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet (2011) 2.85
Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol (2012) 2.57
Simulating video-assisted thoracoscopic lobectomy: a virtual reality cognitive task simulation. J Thorac Cardiovasc Surg (2011) 2.38
Prone vs supine positioning for breast cancer radiotherapy. JAMA (2012) 2.32
Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis. Chest (2008) 2.29
Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med (2002) 2.26
Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med (2007) 2.24
Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med (2005) 2.11
Nanoparticles as recyclable catalysts: the frontier between homogeneous and heterogeneous catalysis. Angew Chem Int Ed Engl (2005) 2.09
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Effect of mesenchymal stem cells on skin graft to flap prefabrication: an experimental study. Ann Plast Surg (2010) 2.03
Survival in familial dysautonomia: Impact of early intervention. J Pediatr (2002) 1.98
Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome (2013) 1.98
A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet (2011) 1.98
Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res (2010) 1.94
Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res (2009) 1.86
Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. Am J Respir Crit Care Med (2011) 1.86
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. J Clin Oncol (2010) 1.83
Inflammatory biomarkers predict airflow obstruction after exposure to World Trade Center dust. Chest (2012) 1.78
Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol (2002) 1.75
Small pulmonary nodules: volume measurement at chest CT--phantom study. Radiology (2003) 1.73
Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol (2004) 1.73
Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest (2002) 1.72
CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology (2004) 1.71
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med (2013) 1.69
Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.68
Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) (2010) 1.68
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One (2010) 1.66
Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark (2007) 1.60
Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res (2005) 1.59
Wavelet compression of low-dose chest CT data: effect on lung nodule detection. Radiology (2003) 1.58
Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res (2005) 1.52
Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2004) 1.51
Adaptation of a visualized loop-mediated isothermal amplification technique for field detection of Plasmodium vivax infection. Parasit Vectors (2011) 1.48
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res (2012) 1.46
Reconstruction of the face and neck scar contractures using staged transfer of expanded "Super-thin flaps". Burns (2007) 1.44
Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med (2002) 1.43
Obstructive airways disease with air trapping among firefighters exposed to World Trade Center dust. Chest (2009) 1.43
Octanuclear metallocyclic Ni4Fc4 compound: synthesis, crystal structure, and electrochemical sensing for Mg2+. Inorg Chem (2004) 1.40
Clinical presentation of asbestosis with intractable pleural pain in the adult child of a taconite miner and radiographic demonstration of the probable pathology causing the pain. Int J Occup Environ Health (2009) 1.39
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum Gene Ther (2003) 1.35
Long-term inhalation exposure to nickel nanoparticles exacerbated atherosclerosis in a susceptible mouse model. Environ Health Perspect (2010) 1.34
A genome-wide association study in Chinese men identifies three risk loci for non-obstructive azoospermia. Nat Genet (2011) 1.33
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg (2013) 1.31
Obliterative bronchiolitis. N Engl J Med (2014) 1.31
microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol (2013) 1.31
Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol (2006) 1.29
Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice. Infect Immun (2002) 1.29
Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem (2003) 1.29
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer (2005) 1.28
Silencing polygalacturonase expression inhibits tomato petiole abscission. J Exp Bot (2008) 1.27
Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med (2002) 1.27
Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system. Clin Cancer Res (2011) 1.24
Imaging of thalamocortical dysrhythmia in neuropsychiatry. Front Hum Neurosci (2011) 1.24
A subgroup of MYB transcription factor genes undergoes highly conserved alternative splicing in Arabidopsis and rice. J Exp Bot (2006) 1.23
Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg (2002) 1.23
Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol (2007) 1.23
Bronchiolar disorders: a clinical-radiological diagnostic algorithm. Chest (2010) 1.22
Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta (2008) 1.21
Pulmonary response after exposure to inhaled nickel hydroxide nanoparticles: short and long-term studies in mice. Nanotoxicology (2010) 1.20
Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol (2010) 1.20
Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial. J Thorac Oncol (2009) 1.20
Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. J Proteome Res (2010) 1.18
Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure. Chest (2007) 1.18
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17
Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One (2009) 1.17
Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis. J Immunol (2008) 1.15
Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2005) 1.13
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Res Treat (2010) 1.12
Characteristics of a residential and working community with diverse exposure to World Trade Center dust, gas, and fumes. J Occup Environ Med (2009) 1.12
4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis (2002) 1.12
Detection of Plasmodium vivax infection in the Republic of Korea by loop-mediated isothermal amplification (LAMP). Acta Trop (2009) 1.12
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest (2015) 1.11
Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol (2004) 1.11
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2012) 1.10
Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys (2012) 1.10
Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF. Cell Biol Int (2013) 1.09
Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis. J Infect Dis (2007) 1.08
Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect Immun (2003) 1.07
Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res (2007) 1.07
Hedgehog signaling in neonatal and adult lung. Am J Respir Cell Mol Biol (2013) 1.06
Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol (2005) 1.06
Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res (2012) 1.05
HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway. Am J Respir Cell Mol Biol (2007) 1.05
Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein. Hum Gene Ther (2002) 1.05